Expensive cancer therapies: unintended effects

J Natl Cancer Inst. 2015 Jan 6;107(1):497. doi: 10.1093/jnci/dju497. Print 2015 Jan.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Drug Approval*
  • Drug Costs* / trends
  • Drug Industry / economics
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / economics
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents